Investigator
Malene Hansen
BUCK INSTITUTE FOR RESEARCH ON AGING · funded by NIA
- Companies
- 4
- Grants
- 4
- Non-dilutive funding
- $2.1M
- First award
- Aug 15, 2011
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 30, 2021.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
NeuroGrant-only
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
NeuroGrant-only
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
NeuroGrant-only
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- U54
Senescence tissue mapping and SASP Atlas for human somatic and reproductive tissues
$515kSep 30, 2021NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11176279 (opens the source filing in a new tab)
- R01
Role of Selective Autophagy in Organismal Health
$479kAug 15, 2021NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11078706 (opens the source filing in a new tab)
- R01
Role of Selective Autophagy in Organismal Health
$484kAug 15, 2021NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11330203 (opens the source filing in a new tab)
- R01
Regulation of the Autophagy Pathway with Age and in Long-lived Animals
$653kAug 15, 2011NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11245723 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources